Retail sale of pharmaceutical products
AARVOLD ØYLI HOLDING AS
Revenue 2024
NOK 0
Operating profit
NOK −4,000
Equity
NOK 1.8m
Incorporated
2019
Share capital
NOK 30,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 0 | |
| Total operating costs | 4k | |
| Operating profit (EBIT) | −4k | |
| Net financial items | −1.8m | |
| Profit for the year | −2.1m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 2.0m | |
| of which current assets | 1.9m | |
| Equity | 1.8m | |
| Total liabilities | 267k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.